Skip to Content

Stelara Approval History

Stelara (ustekinumab) is a human monoclonal antibody for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and moderately to severely active Crohn's disease.

Development History and FDA Approval Process for Stelara

Sep 26, 2016Approval FDA Approves Stelara (ustekinumab) for Treatment of Adults with Moderately to Severely Active Crohn's Disease
Sep 23, 2013Approval Stelara (ustekinumab) Receives FDA Approval to Treat Active Psoriatic Arthritis
Sep 25, 2009Approval FDA Approves Stelara (ustekinumab) to Treat Psoriasis
May 27, 2009FDA Extends Review Timeline for Stelara (ustekinumab) Biologic License Application by Three Months
Dec 19, 2008FDA Issues Complete Response Letter to Centocor for Ustekinumab Biologic License Application
Aug  8, 2008FDA Extends Review Timeline for Ustekinumab Biologic License Application Three Months
Jun 18, 2008FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
Feb  4, 2008Centocor Announces Ustekinumab Biologic License Application Accepted for Filing by FDA
Dec  7, 2007Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis
Dec  4, 2007Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.